Literature DB >> 27347075

Network analysis of microRNAs, transcription factors, target genes and host genes in human anaplastic astrocytoma.

Luchen Xue1, Zhiwen Xu2, Kunhao Wang2, Ning Wang2, Xiaoxu Zhang1, Shang Wang2.   

Abstract

Numerous studies have investigated the roles played by various genes and microRNAs (miRNAs) in neoplasms, including anaplastic astrocytoma (AA). However, the specific regulatory mechanisms involving these genes and miRNAs remain unclear. In the present study, associated biological factors (miRNAs, transcription factors, target genes and host genes) from existing studies of human AA were combined methodically through the interactions between genes and miRNAs, as opposed to studying one or several. Three regulatory networks, including abnormally expressed, related and global networks were constructed with the aim of identifying significant gene and miRNA pathways. Each network is composed of three associations between miRNAs targeted at genes, transcription factors (TFs) regulating miRNAs and miRNAs located on their host genes. Among these, the abnormally expressed network, which involves the pathways of previously identified abnormally expressed genes and miRNAs, partially indicated the regulatory mechanism underlying AA. The network contains numerous abnormal regulation associations when AA emerges. By modifying the abnormally expressed network factors to a normal expression pattern, the faulty regulation may be corrected and tumorigenesis of AA may be prevented. Certain specific pathways are highlighted in AA, for example PTEN which is targeted by miR-21 and miR-106b, regulates miR-25 which in turn targets TP53. PTEN and miR-21 have been observed to form feedback loops. Furthermore, by comparing and analyzing the pathway predecessors and successors of abnormally expressed genes and miRNAs in three networks, similarities and differences of regulatory pathways may be identified and proposed. In summary, the present study aids in elucidating the occurrence, mechanism, prevention and treatment of AA. These results may aid further investigation into therapeutic approaches for this disease.

Entities:  

Keywords:  anaplastic astrocytoma; host gene; microRNA; network; target gene; transcription factor

Year:  2016        PMID: 27347075      PMCID: PMC4906628          DOI: 10.3892/etm.2016.3272

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  31 in total

1.  Gene regulation by transcription factors and microRNAs.

Authors:  Oliver Hobert
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

2.  Cancer statistics, 1999.

Authors:  S H Landis; T Murray; S Bolden; P A Wingo
Journal:  CA Cancer J Clin       Date:  1999 Jan-Feb       Impact factor: 508.702

Review 3.  Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma.

Authors:  Yukitaka Ushio; Kenji Tada; Shoji Shiraishi; Takanori Kamiryo; Naoki Shinojima; Masato Kochi; Hideyuki Saya
Journal:  Front Biosci       Date:  2003-05-01

4.  MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.

Authors:  Yanlei Guan; Masahiro Mizoguchi; Koji Yoshimoto; Nobuhiro Hata; Tadahisa Shono; Satoshi O Suzuki; Yukie Araki; Daisuke Kuga; Akira Nakamizo; Toshiyuki Amano; Xinlong Ma; Kenshi Hayashi; Tomio Sasaki
Journal:  Clin Cancer Res       Date:  2010-07-02       Impact factor: 12.531

5.  Genome-wide oligonucleotide microarray analysis of gene-expression profiles of Taiwanese patients with anaplastic astrocytoma and glioblastoma multiforme.

Authors:  Chia-Lin Chang
Journal:  J Biomol Screen       Date:  2008-09-23

6.  GeneCards Version 3: the human gene integrator.

Authors:  Marilyn Safran; Irina Dalah; Justin Alexander; Naomi Rosen; Tsippi Iny Stein; Michael Shmoish; Noam Nativ; Iris Bahir; Tirza Doniger; Hagit Krug; Alexandra Sirota-Madi; Tsviya Olender; Yaron Golan; Gil Stelzer; Arye Harel; Doron Lancet
Journal:  Database (Oxford)       Date:  2010-08-05       Impact factor: 3.451

7.  The UCSC Genome Browser database: update 2011.

Authors:  Pauline A Fujita; Brooke Rhead; Ann S Zweig; Angie S Hinrichs; Donna Karolchik; Melissa S Cline; Mary Goldman; Galt P Barber; Hiram Clawson; Antonio Coelho; Mark Diekhans; Timothy R Dreszer; Belinda M Giardine; Rachel A Harte; Jennifer Hillman-Jackson; Fan Hsu; Vanessa Kirkup; Robert M Kuhn; Katrina Learned; Chin H Li; Laurence R Meyer; Andy Pohl; Brian J Raney; Kate R Rosenbloom; Kayla E Smith; David Haussler; W James Kent
Journal:  Nucleic Acids Res       Date:  2010-10-18       Impact factor: 16.971

8.  miRecords: an integrated resource for microRNA-target interactions.

Authors:  Feifei Xiao; Zhixiang Zuo; Guoshuai Cai; Shuli Kang; Xiaolian Gao; Tongbin Li
Journal:  Nucleic Acids Res       Date:  2008-11-07       Impact factor: 16.971

9.  The database of experimentally supported targets: a functional update of TarBase.

Authors:  Giorgos L Papadopoulos; Martin Reczko; Victor A Simossis; Praveen Sethupathy; Artemis G Hatzigeorgiou
Journal:  Nucleic Acids Res       Date:  2008-10-27       Impact factor: 16.971

10.  miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions.

Authors:  Sheng-Da Hsu; Yu-Ting Tseng; Sirjana Shrestha; Yu-Ling Lin; Anas Khaleel; Chih-Hung Chou; Chao-Fang Chu; Hsi-Yuan Huang; Ching-Min Lin; Shu-Yi Ho; Ting-Yan Jian; Feng-Mao Lin; Tzu-Hao Chang; Shun-Long Weng; Kuang-Wen Liao; I-En Liao; Chun-Chi Liu; Hsien-Da Huang
Journal:  Nucleic Acids Res       Date:  2013-12-04       Impact factor: 16.971

View more
  2 in total

1.  Upregulation of miR‑598 promotes cell proliferation and cell cycle progression in human colorectal carcinoma by suppressing INPP5E expression.

Authors:  Kun-Ping Li; Yong-Ping Fang; Jin-Qi Liao; Jin-Dong Duan; Li-Guang Feng; Xiao-Zai Luo; Zhi-Jian Liang
Journal:  Mol Med Rep       Date:  2017-12-06       Impact factor: 2.952

Review 2.  A myriad of roles of miR-25 in health and disease.

Authors:  Márta Sárközy; Zsuzsanna Kahán; Tamás Csont
Journal:  Oncotarget       Date:  2018-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.